Here’s whether Bausch Health Companies Inc (BHC) is worth buying in 2026 —
based on weekly-updated price trend, RSI momentum, and return vs.
the S&P 500. Our current read: Bullish.
🟢
Bullish
Positives: trading above the 200-day MA (long-term uptrend intact); above the 50-day MA (medium-term momentum positive); 50-day MA is rising (+5.17% over 10 days); RSI 40 — healthy momentum range; 3-month momentum positive (+17.7%). Concerns: weak 1-year return of -14.1%; declining volume on rally — weak conviction (0.60x 30d avg). Currently 19.5% off its 52-week high. Score: +4/7.
BHC is in a confirmed uptrend, trading above both its 50-day ($5.37) and 200-day ($5.86) moving averages. An RSI of 40.3 sits in the neutral zone — momentum is neither stretched nor exhausted. The 1-year return of -14.1% compares to +20.5% for SPY (trailed the market by 34.6%).
$10,000 invested 1 year ago→ $8,587 today
vs. S&P 500 (SPY) — same period trailed market by 34.6%